Late Breaking Abstract- Depemokimab efficacy/safety in patients with asthma on medium/high-dose ICS: The Phase IIIA randomised SWIFT-1/2 studies

Category Primary study
JournalEUROPEAN RESPIRATORY JOURNAL
Year 2024
This article has no abstract
Epistemonikos ID: 1c06fa37ca1830dc67167e61551dde9516f382bb
First added on: Feb 07, 2025